Common Medications Leave Lasting Gut Microbiome Fingerprints Years After Use

Medications you stopped taking years ago may still be actively reshaping your gut microbiome, according to a study from the University of Tartu Institute of Genomics published in ScienceDaily.

Researchers analyzed stool samples and prescription histories from more than 2,500 participants in the Estonian Biobank, discovering that drug-induced microbial "fingerprints" can persist long after treatment ends.

  • Researchers identified persistent microbial changes from antibiotics, antidepressants, beta-blockers, proton pump inhibitors, and benzodiazepines.
  • The study utilized shotgun sequencing to link individual stool samples to years of electronic health records.

While antibiotics are well known for their impact on digestive health, this study highlights that many other common treatments leave lasting marks. According to ScienceDaily, beta-blockers, proton pump inhibitors, and antidepressants were all linked to long-term shifts in gut bacteria.

Benzodiazepines, used to treat anxiety, showed effects on the microbiome comparable to those of broad-spectrum antibiotics. However, the researchers discovered that the impact is not uniform across a drug class. "Which benzo" or "which SSRI" could leave different long-term microbial signatures, according to the Estonian Research Council. This heterogeneity implies that the specific chemical composition of a drug may determine how strongly it disrupts the microbial community.

To verify that these medications were the drivers of change, the team examined a subset of 328 participants who had started or stopped specific treatments. By observing predictable shifts in gut bacteria during these periods, the researchers provided evidence that the drugs contribute to changes rather than merely coinciding with them, ScienceDaily reported.

The team also noted a dose-history relationship, where the frequency or duration of past medication use correlated with the strength of the detectable microbial impact.

By linking these samples to years of electronic prescription records, they provided a comprehensive look at how historical drug use shapes the gut environment.

The study highlights that heterogeneity matters when assessing medical impacts on the digestive tract. According to the Estonian Research Council on October 9, 2025, specific choices such as “which benzo” or “which SSRI” could leave different long-term microbial signatures within a patient.

This variability suggests that the specific chemical composition of a medication is a critical factor in how it disrupts the microbial community over time. These results demonstrate why accounting for a patient’s full medication history is essential for accurate clinical interpretation.

The discovery that past prescriptions act as a "hidden confounder" suggests that scientists may have previously attributed certain microbial differences to diseases when they were actually caused by earlier drug exposure.

While these persistent changes are clear, their long-term health implications remain unestablished. "This is a comprehensive systematic evaluation of long-term medication effects on the microbiome using real-world medical health records," said Professor Elin Org, corresponding author. "We hope this encourages researchers and clinicians to factor in medication history when interpreting microbiome data."

Photo of author

Health Desk

Health Desk at Archyde.

St. Johns River Hits Record Level, State Road 46 Closed for Days After Heavy Rain

Asus ProArt GR1X Mini PC Available in Four European Markets with Nvidia Grace Blackwell